Epidemiological Study of Treatment Approaches on AQP4-IgG Positive NMOSD in Russia

Clinical trial NCT07247292 · TERMINATED

Trial details

NCT number: NCT07247292
Sponsor: AstraZeneca
Status: TERMINATED
Study type: OBSERVATIONAL

Rare Diseases Neuromyelitis Optica Spectrum Disorder (NMOSD)

Start date: 2025-12-23
Primary completion: 2026-02-26
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.